Although LYN is well-known to balance the B cell receptor (BCR) response, activation of this kinase seemed to play only a minor role in B-CLL development, as loss- and gain-of-function mutants of LYN in B cells did not significantly alter CLL progression in murine models2,20,21. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.